J&J Remicade Sales Aid Cited By FDA For “Misleading” Efficacy Claims
Executive Summary
A Remicade sales aid contains unsubstantiated effectiveness claims and omits risk information, the Center for Drug Evaluation & Research's advertising division says in a Feb. 11 "untitled" letter to Johnson & Johnson's Centocor division